Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia

Clin Infect Dis. 2010 Aug 1;51 Suppl 1(Suppl 1):S150-70. doi: 10.1086/653065.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Clinical Trials as Topic*
  • Cross Infection / drug therapy*
  • Endpoint Determination
  • Hospitals
  • Humans
  • Patient Selection
  • Pneumonia, Bacterial / drug therapy*
  • Pneumonia, Ventilator-Associated / drug therapy*
  • Research Design
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Bacterial Agents